Study of pain management in advanced cancer patients in a tertiary care hospital in India

Bisht, Manisha; Bist, Sampan Singh; Dhamana, D. C.; Saini, S.
January 2011
Tropical Doctor;Jan2011, Vol. 41 Issue 1, p31
Academic Journal
This observational study was carried out to investigate the pain management of 100 advanced cancer patients in a multi disciplinary academic centre. Ninety-five percent of patients reported substantial pain, 66% of patients received inadequate analgesics and only 6.32% received strong opioids. This study revealed that pain management was insufficient at the investigated institute, which could be attributed to the restricted use of strong opioids.


Related Articles

  • Fentanyl Effervescent Buccal Tablet. Cada, Dennis J.; Levien, Terri; Baker, Danial E. // Hospital Pharmacy;Mar2007, Vol. 42 Issue 3, p230 

    The article provides information on fentanyl effervescent buccal tablet. It is said that the tablets are indicated for breakthrough pain management in patients with cancer who are already receiving and are tolerant to opioid therapy. Fentanyl is said to be a potent opioid analgesic and produces...

  • The Prevalence of Drug Abuse and Substance Dependency Among Cancer Patients in Mazandaran. Hedayatizadeh-Omran, Akbar; Hosseini, Seyed Hamzeh; Salehifar, Ebrahim; Moosanejhad, Nadali // Journal of Mazandaran University of Medical Sciences (JMUMS);Dec2010/Jan2011, Vol. 20 Issue 79, p39 

    No abstract available.

  • A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain. Takahashi, Hidenori; Shimoyama, Naohito // International Journal of Clinical Oncology;Feb2010, Vol. 15 Issue 1, p46 

    Neuropathic pain is regarded as one of the main causes of cancer pain refractory to standard opioid therapy in palliative care. The use of adjuvant analgesics for neuropathic cancer pain is largely empirical and the true efficacy of these adjuvant analgesics has been unknown. Gabapentin is one...

  • Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. Arai, Young-Chang P.; Matsubara, Takako; Shimo, Kazuhiro; Suetomi, Katsutoshi; Nishihara, Makoto; Ushida, Takahiro; Kobayashi, Kunio; Suzuki, Chiharu; Kinoshita, Akiko; Kondo, Miki; Matsubara, Satuki; Hayashi, Ruiko; Tohyama, Yukio; Nishida, Kikuyo; Arakawa, Maki // Journal of Anesthesia;2010, Vol. 24 Issue 3, p407 

    Painful neuropathic conditions of cancer pain often show little response to nonopioid and opioid analgesics but may be eased by antidepressants and anticonvulsants. Although gabapentin is effective in the treatment of neuropathic pain in patients with cancer, some patients experience intolerable...

  • Meeting the Challenges in Cancer Pain Management.  // ONS News;Sep2004 Supplement, Vol. 19, p9 

    The article discusses the strategies for cancer pain management that nurses can share with patients experiencing pain. Cancer pain is caused by the disease itself or its treatments. The discussion covers important topics such as variables that must be considered when selecting an initial opioid...

  • Pain control in the ambulatory elderly. Bernstein, Lawrence H.; Enck, Robert E. // Geriatrics;Mar1991, Vol. 46 Issue 3, p49 

    Pain control in the elderly, no matter what the etiology or setting, can be a major clinical challenge. Aging causes unique physiologic changes, eg, a decreased perception of pain and an enhanced sensitivity to opioid analgesics. Principles regarding evaluation of patients with pain are...

  • Fentanyl Buccal Tablet: In Breakthrough Pain in Opioid-Tolerant Patients with Cancer. Blick, Stephanie K. A.; Wagstaff, Antona J. // Drugs;2006, Vol. 66 Issue 18, p2387 

    â–´ The fentanyl buccal tablet (FBT) is a new formulation of fentanyl that uses an effervescent drug delivery system to enhance penetration across the buccal mucosa for the treatment of breakthrough pain in opioid-tolerant patients with cancer.â–´ Fentanyl is rapidly absorbed from FBT...

  • First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study. García de Paredes, M. L.; del Moral González, F.; Martínez del Prado, P.; Martí Ciriquián, J. L.; Enrech Francés, S.; Cobo Dols, M.; Esteban González, E.; Ortega Granados, A. L.; Majem Tarruella, M.; Cumplido Burón, J. D.; Gascó Hernández, A.; López Miranda, E.; Ciria Santos, J. P.; de Castro Carpeño, F. J. // Annals of Oncology;Apr2011, Vol. 22 Issue 4, p924 

    Background: Thirty percent to ninety percent of cancer patients suffer from pain, including neuropathic pain (NP), which results in great burden for cancer patients. Thus, it was of great interest to determine NP prevalence in cancer patients in Spain, to raise awareness of the condition, and...

  • Clinical Research on Nourishing Yin and Unblocking Meridians Recipe Combined with Opioid Analgesics in Cancer Pain Management. Zhang Ting; Ma Sheng-lin; Xie Guang-ru; Deng Qing-hua; Tang Zhong-zhu; Pan Xiao-chan; Zhang Min; Xu Su // Chinese Journal of Integrative Medicine;Sep2006, Vol. 12 Issue 3, p180 

    Objective: To investigate the analgesic effects of Nourishing yin and Unblocking meridians Receipe (NUR) combined with opioid analgesics in managing cancer pain. Methods: All the patients enrolled were differentiated as of yin deficiency and meridian blocked syndrome type of TCM. Forty-one of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics